Bramlage, P., Schmieder, R. E., Gitt, A. K., Baumgart, P., Mahfoud, F., Buhck, H., . . . Potthoff, S. A. (2015). The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: Insights from the prospective EARLY registry. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).
Chicago-Zitierstil (17. Ausg.)Bramlage, Peter, Roland E. Schmieder, Anselm K. Gitt, Peter Baumgart, Felix Mahfoud, Hartmut Buhck, Taoufik Ouarrak, Martina Ehmen, und Sebastian A. Potthoff. The Renin-angiotensin Receptor Blocker Azilsartan Medoxomil Compared with the Angiotensin-converting Enzyme Inhibitor Ramipril in Clinical Trials Versus Routine Practice: Insights from the Prospective EARLY Registry. Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2015.
MLA-Zitierstil (9. Ausg.)Bramlage, Peter, et al. The Renin-angiotensin Receptor Blocker Azilsartan Medoxomil Compared with the Angiotensin-converting Enzyme Inhibitor Ramipril in Clinical Trials Versus Routine Practice: Insights from the Prospective EARLY Registry. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2015.